Synopsis The global Hemocompatible Coating market size was valued at USD 42 million in 2022 and is forecast to a readjusted size of USD 75 million by 2029 with a CAGR of 8.5% during review period. The influence of COVID-19 and the Russia-Ukraine War were.....
SynopsisA bipolar hip system is a type of implant used in hip replacement surgery to address specific issues related to hip instability, particularly in patients who are at risk of dislocation. The global Bipolar Hip System market was valued at US$ million in 20.....
SynopsisRadiofrequency ablation (RFA) is a medical procedure in which part of the electrical conduction system of the heart, tumor or Others dysfunctional tissue is ablated using the heat generated from medium frequency alternating current (in the range of 350–500 kHz.....
SynopsisUltra-soft exoskeleton is a type of wearable robotic device designed to augment or assist human movement and provide support to the user's body. Unlike traditional exoskeletons that are rigid and bulky, ultra-soft exoskeletons are characterized by their soft a.....
SynopsisThe global Electric Pressure Infusor market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Electric Pressure Infusor is estimated t.....
SynopsisThe global Wound Irrigation Syringe market was valued at US$ 136 million in 2023 and is anticipated to reach US$ 169.1 million by 2030, witnessing a CAGR of 3.2% during the forecast period 2024-2030. According to our research, the global market for medic.....
SynopsisAn artificial urinary sphincter (AUS) is an implanted device to treat urinary incontinence in men. The AUS is designed to supplement the function of the natural urinary sphincter that restricts urine flow out of the bladder. The global Artificial Urinary.....
SynopsisZolmitriptan, sold under the brand name Zomig among others, is a triptan used in the acute treatment of migraine attacks with or without aura and cluster headaches. It is a selective serotonin receptor agonist of the 1B and 1D subtypes. Market Ana.....
SynopsisThe global Shockwave Therapy Device market was valued at US$ 3137 million in 2023 and is anticipated to reach US$ 4630.2 million by 2030, witnessing a CAGR of 5.6% during the forecast period 2024-2030. According to our research, the global market for med.....
SynopsisGemtuzumab ozogamicin is a drug-linked monoclonal antibody (an antibody-drug conjugate) that was used to treat acute myeloid leukemia from 2000 to 2010. The global Gemtuzumab Ozogamicin Drugs market size is expected to reach US$ 179.5 million by 2029, gr.....
